A. Ekman

发表

The intrinsic activity of (−)-3-PPP vis-à-vis prolactin-suppressing dopamine D2 receptors in transfected GH4C1 cells is dependent on which secretagogue that is used to provoke prolactin release

E. Eriksson, C. Nilsson, M. Hellstrand, 1998, Neuropharmacology.

Ethanol decreases nocturnal plasma levels of thyrotropin and growth hormone but not those of thyroid hormones or prolactin in man.

M. Knip, A. Ruokonen, O. Vakkuri, 1996, The Journal of clinical endocrinology and metabolism.

The ser9gly SNP in the dopamine D3 receptor causes a shift from cAMP related to PGE2 related signal transduction mechanisms in transfected CHO cells

V. Steen, E. Eriksson, C. Nilsson, 2004, Journal of Medical Genetics.

Effects of the two partial D2 agonists (+)- and (-)-3-PPP on prolactin release in EEDQ treated male rats.

E. Eriksson, A. Ekman, M. Quiding, 1991, Life sciences.

Pituitary and brain D2 receptor density measured in vitro and in vivo in EEDQ treated male rats.

E. Eriksson, A. Ekman, 1991, Life sciences.

The Effects of 1‐Methyl‐4‐phenylpyridinium Ion (MPP+) on the Efflux and Metabolism of Endogenous Dopamine in Rat Striatal Slices

A. Carlsson, A. Ekman, E. Pileblad, 1988, The Journal of pharmacy and pharmacology.

Ethanol induces a paradoxical simultaneous increase in circulating concentrations of insulin-like growth factor binding protein-1 and insulin.

M. Knip, O. Vakkuri, J. Leppäluoto, 1995, Metabolism: clinical and experimental.

Low density and high affinity of platelet [3H]paroxetine binding in women with bulimia nervosa

M. Landén, E. Eriksson, A. Ekman, 2006, Psychiatry Research.

Ethanol inhibits melatonin secretion in healthy volunteers in a dose-dependent randomized double blind cross-over study.

O. Vakkuri, J. Leppäluoto, A. Ekman, 1993, The Journal of clinical endocrinology and metabolism.

Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors

M. Piercey, A. Carlsson, W. E. Hoffmann, 1991, Naunyn-Schmiedeberg's Archives of Pharmacology.

Environment-dependent effects of ethanol on DOPAC and HVA in various brain regions of ethanol-tolerant rats

J. Engel, B. Söderpalm, A. Ekman, 2005, Psychopharmacology.

Escitalopram Administered in the Luteal Phase Exerts a Marked and Dose-Dependent Effect in Premenstrual Dysphoric Disorder

E. Eriksson, H. Nissbrandt, A. Ekman, 2008, Journal of clinical psychopharmacology.

Delayed pro-opiomelanocortin activation after ethanol intake in man.

O. Vuolteenaho, O. Vakkuri, J. Leppäluoto, 1994, Alcoholism, clinical and experimental research.

6,7,8,9-Tetrahydro-N,N-di-n-propyl-3H-benzindol-8-amines. Derivatives as potent and orally active serotonin 5-HT1A receptor agonists.

J. Nilsson, A. Carlsson, K. Svensson, 1994, Journal of medicinal chemistry.

Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo.

A. Carlsson, L. J. King, K. Svensson, 1993, Journal of medicinal chemistry.

5-, 6-, 7- and 8-amino-2-(N,N-di-n-propylamino)-1,2,3,4-tetrahydronaphthalenes: centrally acting DA and 5-HT1A agonists

A. Carlsson, K. Svensson, A. Ekman, 1993 .

Effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on the prolactin suppression induced by a series of full and partial dopamine D2 receptor agonists in male rats

E. Eriksson, A. Ekman, 1992, Naunyn-Schmiedeberg's Archives of Pharmacology.

A high dose of EEDQ reduces pituitary dopamine D2 receptor density and the prolactin suppressive potency of agonists.

E. Eriksson, A. Ekman, 1993, European journal of pharmacology.

(S)- and (R)-8-(Di-n-propylamino)-6,7,8,9-tetrahydro-3H-benz(e)indole- 1-carbaldehyde : A New Class of Orally Active 5HT1A-Receptor Agonists.

A. Carlsson, S. Sundell, K. Svensson, 1994 .

(S)- and (R)-8-(di-n-propylamino)-6,7,8,9-tetrahydro-3H-benz[e]indole-1- carbaldehyde: a new class of orally active 5-HT1A-receptor agonists.

A. Carlsson, S. Sundell, K. Svensson, 1993, Journal of medicinal chemistry.

Ethanol decreases nocturnal plasma levels of atrial natriuretic peptide (ANP 99-126) but not the N-terminal fragment of pro-atrial natriuretic peptide (ANP 1-98) in man.

O. Vuolteenaho, O. Vakkuri, J. Leppäluoto, 1994, Clinical science.

Central administration of dopamine D3 receptor antisense to rat: effects on locomotion, dopamine release and [3H]spiperone binding

M. Heilig, E. Eriksson, H. Nissbrandt, 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

Both dopamine and the putative dopamine D3 receptor antagonist PNU-99194A induce a biphasic inhibition of phorbol ester-stimulated arachidonic acid release from CHO cells transfected with the dopamine D3 receptor.

E. Eriksson, C. Nilsson, M. Hellstrand, 1999, Life sciences.

Direct dopamine D2‐receptor‐mediated modulation of arachidonic acid release in transfected CHO cells without the concomitant administration of a Ca2+‐mobilizing agent

E. Eriksson, C. Nilsson, M. Hellstrand, 1998, British journal of pharmacology.

Inverse Agonism at Dopamine D2 Receptors

E. Eriksson, C. Nilsson, M. Hellstrand, 1996, Neuropsychopharmacology.

Dopamine D3 receptor antisense influences dopamine synthesis in rat brain.

M. Heilig, E. Eriksson, H. Nissbrandt, 1995, Neuroreport.